Approval · Notice of Compliance 32910 · 2024
ATARAX: Notice of Compliance 32910
Issued March 19, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32910
- Date
- March 19, 2024
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the label to align with the current Plain Language Labelling (PLL) Regulations.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATARAX | Not yet assigned | — |
Medicinal ingredients
- HYDROXYZINE HCL 10 MG per 5ML